文献速递胸部肿瘤

胸外科医师实施的微创肺癌手术与开胸术效果相当

Minimally Invasive Lung Cancer Surgery Performed by Thoracic Surgeons as Effective as Thoracotomy.
PubMed 文献 · J Clin Oncol · 2018-05-23

该回顾性队列非劣效性研究基于STS数据库与Medicare链接数据,分析2002-2013年>65岁临床I期肺癌行肺叶切除术患者共10,597例(开胸4,448例,VATS 6,149例)。

要点

  • VATS肺叶切除在临床I期肺癌中远期疗效不劣于开胸
  • 近期时代VATS死亡风险显著低于开胸(HR 0.84)
  • 倾向匹配后VATS 4年生存率略优于开胸

核心结论

  • 由认证胸外科医师实施的VATS肺叶切除治疗I期肺癌,其长期疗效不劣于开胸术。

研究设计与样本

  • 回顾性队列非劣效性研究,数据来自STS General Thoracic Surgery Database与Medicare链接。
  • 纳入2002-2013年>65岁临床I期肺癌行肺叶切除术患者10,597例,其中开胸4,448例,VATS 6,149例。

主要发现

  • 上述分析在病理I期患者独立队列中重复,结果相似。

临床怎么用

  • 对于I期肺癌肺叶切除术,VATS可作为不劣于开胸的选项,尤其由认证胸外科医师实施时。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Purpose The prevalence of minimally invasive lung cancer surgery using video-assisted thoracic surgery (VATS) has increased dramatically over the past decade, yet recent studies have suggested that the lymph node evaluation during VATS lobectomy is inadequate. We hypothesized that the minimally invasive approach to lobectomy for stage I lung cancer resulted in a longitudinal outcome that was not inferior to thoracotomy. Patients and Methods Patients > 65 years of age who had undergone lobectomy for stage I lung cancer between 2002 and 2013 were analyzed within the Society of Thoracic Surgeons General Thoracic Surgery Database, which had been linked to Medicare data, as part of a retrospective-cohort, noninferiority study. Results A total of 10,597 patients with clinical stage I lung cancer who underwent lobectomy were evaluated (4,448 patients underwent thoracotomy, and 6,149 underwent VATS). VATS patients had a more favorable distribution of all health-related variables, including pulmonary function (59% of VATS patients had intact spirometry v 51% of thoracotomy patients; P < .001). Cox proportional hazards models were performed over two eras to account for an evolving practice standard. The mortality risk associated with the VATS approach was not greater than thoracotomy in either the earlier era (2002 to 2008; hazard ratio, 0.97; 95% CI, 0.87 to 1.09; P = .62) or the more recent era (2009 to 2013; hazard ratio, 0.84; 95% CI, 0.75 to 0.93; P < .001). Kaplan-Meier survival estimates of 2,901 propensity-matched VATS-thoracotomy pairs demonstrated that the 4-year survival associated with VATS (68.6%) was modestly superior to thoracotomy (64.8%; P = .003). The analyses detailed above were replicated in a separate cohort of pathologic stage I patients with similar findings. Conclusion The long-term efficacy of lobectomy for stage I lung cancer performed using the VATS approach by board-certified thoracic surgeons does not seem to be inferior to that of thoracotomy.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Boffa DJ, Kosinski AS, Furnary AP, et al. Minimally Invasive Lung Cancer Surgery Performed by Thoracic Surgeons as Effective as Thoracotomy. J Clin Oncol. 2018. PMID: 29791289. doi:10.1200/JCO.2018.77.8977

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。